Breaking News

Envirotainer Invests in Swiss Airtainer

Gains exclusive global rights to offer the Swiss Airtainer as part of its full product portfolio.

Envirotainer, a provider of secure cold chain solutions for temperature-sensitive pharmaceuticals, has announced a strategic investment in Swiss Airtainer, a pioneer in lightweight container technology. The partnership grants Envirotainer exclusive global rights to offer the Swiss Airtainer as part of its full product portfolio. Swiss Airtainer will focus on scaling up its production capabilities and accelerating its ongoing research and development efforts.  

About the Swiss Airtainer

The Swiss Airtainer is a light active RKN container equipped with solar panels for self-sustaining energy and real-time communications to optimize logistics and reduce emissions. Its design complements Envirotainer’s sustainability-focused portfolio, including the recently launched flagship Releye family.

“Swiss Airtainer’s technology enables significant CO₂ reductions and strengthens our commitment to sustainable innovation,” said Niklas Adamsson, Interim CEO of Envirotainer. Our mission has always been to ensure safe and reliable delivery of critical medicines while minimizing environmental impact.”

“We are proud to join forces with Envirotainer, a company that shares our vision for a more sustainable future. This partnership will accelerate the development and global adoption of smart, low-impact cold chain solutions, says Eduard Seligman, CEO Swiss Airtainer.

Envirotainer’s climate targets are approved by the Science Based Targets initiative, and the company continues to drive circular logistics and impactful partnerships—now further reinforced by Swiss Airtainer.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters